Alkeon Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.5M | Sell |
|
|||||
|
2025
Q2 | $51.2M | Sell |
|
|||||
|
2025
Q1 | $54.1M | Buy |
|
|||||
|
2024
Q4 | $53.3M | Hold |
|
|||||
|
2024
Q3 | $53.9M | Sell |
|
|||||
|
2024
Q2 | $43.9M | Buy |
|
|||||
|
2024
Q1 | $20.8M | Buy |
|
|||||
|
2023
Q4 | $10M | Sell |
|
|||||
|
2023
Q3 | $11.8M | Hold |
|
|||||
|
2023
Q2 | $11.8M | Buy |
|
|||||
|
2023
Q1 | $10.6M | Sell |
|
|||||
|
2022
Q4 | $17.1M | Buy |
|
|||||
|
2022
Q3 | $18.5M | Buy |
|
|||||
|
2022
Q2 | $12.4M | Sell |
|
|||||
|
2022
Q1 | $19.3M | Buy |
|